Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kidney cancer.

Eric M Wallen1, Raj S Pruthi, Geoffrey F Joyce

  • 1Division of Urology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. ewallen@med.unc.edu

The Journal of Urology
|May 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Subspecialization Alignment: How Residents Tailor Experiences Before Fellowship.

Urology practice·2026
Same author

Prostatitis: A Review.

JAMA·2025
Same author

Trends in Urology Resident Surgical Autonomy: What Do ACGME Chief Resident Case Logs Indicate?

Urology·2025
Same author

An Overview of Farm Investigation Findings Associated with Outbreaks of Shiga Toxin-Producing Escherichia coli Infections Linked to Leafy Greens: 2009-2021.

Journal of food protection·2025
Same author

Impact of Subsequent Fellowship on Urology Chief Resident Case Log Volumes.

Journal of surgical education·2025
Same author

Trifecta Outcomes After Use of 3-Dimensional Digital Models for Planning of Robotic Prostatectomy: A Secondary Analysis of a Randomized Clinical Trial.

JAMA network open·2024
Same journal

Multi-institutional Assessment of Performance Metrics for MRI-targeted Transperineal Prostate Biopsy.

The Journal of urology·2026
Same journal

Urinary Supersaturation in a Randomized Trial among Individuals with Recurrent Nephrolithiasis comparing Empiric versus Selective Preventive Therapy: The URINE Trial.

The Journal of urology·2026
Same journal

The FDA Should Allow More BCG Strains into the US Market: How Recent Landmark Trials Expose a Regulatory Paradox.

The Journal of urology·2026
Same journal

Let's Shift the Focus from Death to Life after Fournier's Gangrene.

The Journal of urology·2026
Same journal

Endourology and Nephrolithiasis.

The Journal of urology·2026
Same journal

With great cost comes great responsibility: who will own the rising costs of bladder cancer care?

The Journal of urology·2026
See all related articles

Kidney cancer incidence and healthcare costs are rising in the US, with disparities in care for Black individuals. Increased surveillance and treatment data analysis are recommended to manage this growing burden.

Area of Science:

  • Public Health
  • Health Economics
  • Oncology

Background:

  • Kidney cancer incidence and associated healthcare expenditures have shown a significant upward trend over the past decade.
  • Risk factors such as an aging population, increasing obesity, and hypertension prevalence are projected to exacerbate the disease burden.

Purpose of the Study:

  • To quantify the burden of kidney cancer in the United States.
  • To identify trends in healthcare resource utilization for kidney cancer.
  • To estimate the economic impact of kidney cancer.

Main Methods:

  • Analysis of healthcare resource utilization and economic impact data for kidney cancer.
  • Review of trends in inpatient care, partial nephrectomies, and laparoscopic techniques.
  • Utilized data from Health Care Cost and Utilization Project, Centers for Medicare and Medicaid Services, and Veterans Affairs.

Related Experiment Videos

Main Results:

  • Kidney cancer incidence is increasing, particularly T1 disease, with higher rates and worse survival in the Black population.
  • Total expenditures for kidney cancer reached $401 million in 2000, a 46% increase since 1994, primarily for inpatient care.
  • Adoption of partial nephrectomies and laparoscopic techniques increased, though hospitalization trends varied across datasets.

Conclusions:

  • The rising incidence and costs of kidney cancer necessitate enhanced surveillance systems like tumor registries.
  • Further characterization of treatment costs and effectiveness, especially for metastatic disease and the adoption of minimally invasive techniques, is crucial.
  • Anticipated increases in disease burden due to demographic and risk factor changes require proactive public health strategies.